Navigation Links
Haemonetics Announces Launch of Faster Plasma Collection Protocol
Date:6/16/2008

BRAINTREE, Ma., June 16 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today at the annual meeting of the Plasma Protein Therapeutics Association the launch of a plasma collection software for its PCS(R)2 plasma collection system that reduces plasma donation time by 20%.

Stephen Swenson, General Manager of Global Plasma for Haemonetics, said, "This new software system, with its faster donation times, combined with our recently launched information technology platforms that automate center operations, are significant enhancements to our product offerings. These systems help our plasma customers to better leverage their plasma collection infrastructure by increasing donor throughput and also provide the donor with a more positive donation experience."

"As the global leader in blood management solutions, we are pleased to be continually strengthening our product suite with products, information technology platforms, and business services for blood collectors and hospitals to improve patient outcomes," he added.

The PCS2 software was 510(k) cleared by the U.S. Food and Drug Administration on May 28, 2008. The software can be used with existing PCS2 devices so no device replacement or additional operator training is required. The product will be launched in limited market release, with full market release expected by year end.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com .

Contact:

Julie Fallon

Tel. (781) 356-9517

Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract
2. Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
3. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
4. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
5. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
6. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
7. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
8. Villa St. Benedict Announces New Web Site
9. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
10. Indevus Announces Management Changes
11. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... NetDimensions announced today that Scandinavian Health Limited ... management for consistent implementation of standards and regulatory requirements across SHL companies worldwide. ... improve and streamline their training and employee development programs, which are critical to ...
(Date:3/28/2017)... MA. (PRWEB) , ... March 28, 2017 , ... ... long time members of the Modular Building Institute (MBI), an international modular trade ... in the permanent modular category for the Pagliuca Life Lab at Harvard University. ...
(Date:3/28/2017)... 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), ... novel therapies for metabolic and endocrine disorders, today announced ... Ph.D., will deliver a corporate presentation at H.C. Wainwright ... being held April 3, 2017 at the St. Regis ... this presentation are as follows: ...
(Date:3/28/2017)... NEW YORK , March 28, 2017 /PRNewswire/ ... a highly volatile and unpredictable sector due to ... space. Markets served include medical, agricultural, environmental, and ... these four stocks: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), ... OCRX), and Ocular Therapeutix Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:3/2/2017)... MELBOURNE, Australia , March 2, 2017 ... Therapeutics Ltd (ASX: CYP), has signed an agreement ... researchers from the Monash Biomedicine Discovery Institute and Department ... , to conduct a further preclinical study to support ... the treatment of asthma.  Asthma is ...
(Date:2/27/2017)... WASHINGTON , Feb. 27, 2017   Strategic ... fund, today announced it has led a $3.5 million investment ... collaboration platform. Strategic Cyber Ventures is DC based and ... and Hank Thomas . Ron Gula , ... Tech Ventures, also participated in this series A round ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
Breaking Biology News(10 mins):